Pharmacokinetics of pregabalin in subjects with various degrees of renal function. - Wikidata - wikimedia - TriplyDB

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

http://www.wikidata.org/entity/Q34183762

about

An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs The management of diabetic neuropathy in CKD.Pregabalin: latest safety evidence and clinical implications for the management of neuropathic pain.Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications Pregabalin in acute and chronic pain.Pregabalin-associated myoclonic encephalopathy without evidence of drug accumulation in a patient with acute renal failure Pregabalin: a review of its use in adults with generalized anxiety disorder.Pregabalin for the treatment of generalized anxiety disorder: a novel pharmacologic intervention.Population pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy.Postoperative pain management in patients with chronic kidney disease Two cases of pregabalin neurotoxicity in chronic kidney disease patients Management of chronic pain in the rheumatic diseases with insights for the clinician.Pregabalin: a new neuromodulator with broad therapeutic indications.Safety of pregabalin among hemodialysis patients suffering from uremic pruritus.The pharmacotherapy of chronic pain: a review.A retrospective study to identify risk factors for somnolence and dizziness in patients treated with pregabalin Opioid analgesics increase incidence of somnolence and dizziness as adverse effects of pregabalin: a retrospective study.Pregabalin for the treatment of generalised anxiety disorder.Pregabalin for the treatment of painful neuropathy.Pregabalin for pain management.Effects of pregabalin on visceral pain responses and colonic compliance in rats.New treatment options in the management of fibromyalgia: role of pregabalin.Role of pregabalin in the treatment of generalized anxiety disorder Efficacy and tolerability of pregabalin in partial epilepsy.Pregabalin in the management of partial epilepsy An Observational Longitudinal Study Investigating the Effectiveness of 75 mg Pregabalin Post-Hemodialysis among Uremic Pruritus Patients.Clinical use of pregabalin in the management of central neuropathic pain Treatment of postherpetic neuralgia: focus on pregabalin.Pregabalin for the treatment of postsurgical pain.The use of newer antiepileptic drugs in patients with renal failure.Drug safety evaluation of pregabalin.Pregabalin for the treatment of fibromyalgia.ADMET considerations for restless leg syndrome drug treatments.Understanding the pharmacokinetics of anxiolytic drugs.Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment.Pharmacotherapy of generalized anxiety disorder: focus and update on pregabalin.Pain in chronic kidney disease: a scoping review.ADMET considerations when prescribing novel therapeutics to treat restless legs syndrome.Management of fibromyalgia in older adults.Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease.

P2860

Q28069989-5CB32477-8923-44E6-A6A7-B60E7AB5E340 Q33554396-7FEEA764-286A-4DB8-B5AF-6624981F1CCA Q33949565-383CC74D-FCC9-43D7-930D-409FED791236 Q33996679-A58359AF-CED2-40B6-B041-7FF1622DB63E Q34214071-003CDA9E-E3E3-4B1C-9E99-93AEEC99D678 Q34407163-5CE87314-3760-49A3-852A-894158472FA9 Q34434641-D9101F7F-CE49-4E06-A03C-ACEEB1AFEEAD Q34645876-0658DB21-79B9-414A-AB2B-98372D9D588A Q35120597-6E2B0AE6-CEAC-4C90-B70B-E960881E406C Q35157828-D60B01EC-7694-4066-A0D6-875C11F7A6F3 Q35574349-A32D21AC-1A75-4A54-B7DA-E516ABE57E4F Q36056956-F5060B97-5652-4AA0-A59A-C8DF28D37B51 Q36313119-A2293E7E-5E18-4067-9449-C959602D6A40 Q36346120-6365DE8D-1425-4A9C-A612-DD6D9B44DDB2 Q36411163-2A64B087-4F03-466F-8C2C-46F36C781781 Q36507825-BB7439B9-D1DA-44EA-B780-9F5707E74CF2 Q36508802-8A520169-B78D-47A2-8A61-05E951A8C34B Q36613951-9FFDFCCA-84A9-4B15-9DC9-366C379F29DC Q36673006-C11D6B79-BA09-4DF6-9321-444D0A7D8143 Q36687433-E7163EF5-3DEF-4982-B933-25E10F05B62A Q36938454-B0A0CD40-EC67-4C2B-9F9C-1C7756BE3C03 Q37106971-6AC45E4E-4113-419C-BF40-3B888185CE90 Q37125739-4624A725-F67F-4C87-AA04-D4DF58A62815 Q37203346-09D65825-9C53-4F50-9252-D06DB521BD7A Q37318734-BC8879F3-7300-43B7-92D2-EA6394BFDC6E Q37400129-246163A2-A75E-421A-A729-670982D84A10 Q37418980-EE9F20C9-7FC2-43AE-A3AE-F81062F71972 Q37510614-49764F58-A1B0-4B13-888E-6BBA58CFD5EF Q37803241-56994292-7150-4B40-9F51-6E43C3D6D5FA Q37965704-321BCD22-8B02-48ED-8EC0-21C62D6788DF Q37999052-B6289133-0618-4FD1-BBCB-C7F71463F65F Q38020946-DA71EE55-1730-4E20-BBC7-D137EE5B5B5F Q38027180-B175C03B-304E-4B92-A854-DE83DF9533D9 Q38075049-8A2BC58B-4B94-4135-BF44-0064CDA0A3D9 Q38152329-F16F1BC1-1834-456D-914C-DDF17D074E07 Q38168858-C1380CDD-22F9-4FE8-B72B-BF6FB9602F7A Q38187185-04AE638D-4CCB-415D-91BD-DBEC31A83AAB Q38242390-CE55A1D3-F4CB-45B2-BB28-6745E55E0A4A Q38250183-CCF2E8B0-4376-43AD-A363-37A9C66D6BB9 Q38451960-31AD0462-3C8F-4976-A4BD-C1BEA895998C

P2860

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

http://www.wikidata.org/entity/Q34183762

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

@ast

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

@en

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

@nl

type

label

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

@ast

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

@en

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

@nl

prefLabel

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

@ast

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

@en

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

@nl

P1433

Q34183762-5FCDD92C-FF71-483C-92A8-C6949418C934

P1476

Q34183762-209DF147-7016-4C6B-9AA4-C9CCCCF10763

P2093

Q34183762-22EC93A1-1137-4EA8-A686-EDF64113330E

Q34183762-8C6A004F-29D8-4ED3-B198-A67A87A75D69

Q34183762-A93D6287-BF7B-4FB7-9E35-54640E2BADBB

Q34183762-AD807D84-75BB-4A60-9C85-E1023A55C420

Q34183762-E1BE02F9-B081-4E32-9FF7-F00245FEB210

Q34183762-FAC88CCE-0AD3-4F70-A3CB-201589044411

P2860

Q34183762-12944462-FBE3-4E57-9F88-3CA406E1D12F

Q34183762-36B425CB-68A8-4B27-AB6E-B72CD38A838C

Q34183762-6BF8095A-C326-4D96-9B1A-30A18C037E16

Q34183762-E1D24DC6-420A-4A16-AA3A-944D47CA27C8

Q34183762-FDD3DCD4-C51F-420E-B840-3587F1918ABF

P304

Q34183762-3ACB9F1C-61C6-4CF4-B98B-CC8B0E6B5FF7

P31

Q34183762-AEAA24A1-483F-4F5E-B8E5-B46170B94138

P356

Q34183762-41A4015A-474C-4123-A71E-02220F439BEC

P433

Q34183762-F0D0DA9F-DE4F-4CC5-A12F-BE6D20810DED

P478

Q34183762-8521D203-B062-4C81-96AD-A96FE204A979

P577

Q34183762-E654E4DD-4BA7-4821-9423-24EF94F16BE0

P698

Q34183762-608F2301-9C12-4C48-8945-C64CE81D8392

P356

0091270003251119

P1433

The Journal of Clinical Pharmacology

P1476

Pharmacokinetics of pregabalin in subjects with various degrees of renal function.

@en

P2093

Allen J Sedman

http://www.w3.org/2001/XMLSchema#string

Christine W Alvey

http://www.w3.org/2001/XMLSchema#string

Edward J Randinitis

http://www.w3.org/2001/XMLSchema#string

Edward L Posvar

http://www.w3.org/2001/XMLSchema#string

Howard N Bockbrader

http://www.w3.org/2001/XMLSchema#string

Jack A Cook

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin

Treating epilepsy in the elderly: safety considerations.

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel.

Gabapentin inhibits the substance P-facilitated K(+)-evoked release of [(3)H]glutamate from rat caudial trigeminal nucleus slices.

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex.

P304

277-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0091270003251119

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12638396

http://www.w3.org/2001/XMLSchema#string